All-trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines

被引:0
|
作者
Visani, G
Ottaviani, E
Zauli, G
Tosi, P
Pellacani, A
Isidori, A
Pierpaoli, S
Tura, S
机构
[1] Univ Bologna, Inst Hematol & Med Oncol Seragnoli, I-40126 Bologna, Italy
[2] Inst Human Anat, I-44100 Ferrara, Italy
关键词
all-trans retinoic acid; CD34(+); megakaryocytopoiesis; cytokines; thrombopoietin; chemotherapy; autologous transplantation;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to investigate the direct effects of retinoids on normal adult hematopoietic progenitors, purified CD34(+) cells were seeded in serum-free cultures in the presence of pharmacological (10(-6)) M or physiological (10(-12)) M concentrations of all-trans retinoic acid (ATRA) and 9-cis retinoic acid (9-cis RA) plus combinations of specific cytokines. 10(-6) M ATRA and 9-cis RA significantly decreased the number of granulomacrophagic, erythroid and megakaryocytic (CFU-meg) progenitors. On the other hand, 10(-12) M ATRA significantly promoted the growth of CFU-meg, in the presence either of thrombopoietin or of IL-3 + GM-CSF, and induced a reproducible stimulation of the immature CD34(+)DR(-) subset. In conclusion, our findings suggest that retinoic acids probably play a direct role in normal adult hematopoietic development at both physiological and pharmacological concentrations. The stimulatory effect on megakaryocytopoiesis should be considered in the perspective of a potential use of low-dose ATRA, combined with thrombopoietin or other cytokines, in pathological conditions where the megakaryocytic compartment is impaired and the stimulation of megakaryocytopoiesis is requested.
引用
收藏
页码:149 / 153
页数:5
相关论文
共 50 条
  • [41] Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor
    W.-K. Hofmann
    A. Ganser
    G. Seipelt
    O. G. Ottmann
    C. Zander
    G. Geißler
    K. Hoffmann
    K. Höffken
    J. T. Fischer
    G. Isele
    D. Hoelzer
    Annals of Hematology, 1999, 78 : 125 - 130
  • [42] Apoptosis of Glioblastoma U251 Cells Induced by Carmustine Combined All-trans Retinoic Acid via Regulating Cyclin E and p27kip 1
    QI Bin1
    2. Department of Neurosurgery
    4. Department of Neurosurgery
    ChemicalResearchinChineseUniversities, 2011, 27 (05) : 827 - 831
  • [43] Apoptosis of Glioblastoma U251 Cells Induced by Carmustine Combined All-trans Retinoic Acid via Regulating Cyclin E and p27kip 1
    Qi Bin
    Wei Jun
    Hu Guo-zhang
    Yang Hong-fa
    Bi Chun-hua
    Sun Zhi-gang
    Tian Yu
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2011, 27 (05) : 827 - 831
  • [44] Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia
    Sacchi, S
    Kantarjian, HM
    Freireich, EJ
    O'Brien, SO
    Cortes, J
    Rios, MB
    Kornblau, S
    Giles, FJ
    Koller, C
    Gajewski, J
    Talpaz, M
    LEUKEMIA & LYMPHOMA, 1999, 35 (5-6) : 483 - 489
  • [45] Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy
    Gronningsaeter, Ida Sofie
    Fredly, Hanne Kristin
    Gjertsen, Bjorn Tore
    Hatfield, Kimberley Joanne
    Bruserud, Oystein
    CELLS, 2019, 8 (10)
  • [46] All-trans retinoic acid combined with 5-Aza-2′-deoxycitidine induces C/EBPα expression and growth inhibition in MLL-AF9-positive leukemic cells
    Fujiki, Atsushi
    Imamura, Toshihiko
    Sakamoto, Kenichi
    Kawashima, Sachiko
    Yoshida, Hideki
    Hirashima, Yoshifumi
    Miyachi, Mitsuru
    Yagyu, Shigeki
    Nakatani, Takuya
    Sugita, Kanji
    Hosoi, Hajime
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 428 (02) : 216 - 223
  • [47] Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the BCOR-RARA fusion gene
    Chen, Li
    Zhu, Hongming
    Zhu, Yongmei
    Jin, Wen
    Dong, Fangyi
    Li, Jianfeng
    Hu, Jiong
    Chen, Qiusheng
    Wang, Kankan
    Li, Junmin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study
    Sun, Juxian
    Mao, Feifei
    Liu, Chang
    Zhang, Fan
    Jiang, Dafeng
    Guo, Weixing
    Huo, Lei
    Zhou, Liping
    Lau, Wan Yee
    Shi, Jie
    Cheng, Shuqun
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [49] A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
    Burnett, Alan K.
    Milligan, Donald
    Prentice, Archie G.
    Goldstone, Anthony H.
    McMullin, Mary F.
    Hills, Robert K.
    Wheatley, Keith
    CANCER, 2007, 109 (06) : 1114 - 1124
  • [50] Randomized phase-III study of low-dose cytarabine and etoposide? plus ?/- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia
    Schlenk, R. F.
    Weber, D.
    Krzykalla, J.
    Kindler, T.
    Wulf, G.
    Hertenstein, B.
    Salih, H. R.
    Suedhoff, T.
    Krauter, J.
    Martens, U.
    Wessendorf, S.
    Runde, V.
    Tischler, H. J.
    Bentz, M.
    Koller, E.
    Heuser, M.
    Thol, F.
    Benner, A.
    Ganser, A.
    Doehner, K.
    Doehner, H.
    SCIENTIFIC REPORTS, 2023, 13 (01)